Organization
Division of Clinical Epidemiology, Research Institute of the McGill Univ. Health, Montreal, Canada
2 abstracts
Abstract
AN ESTIMATE OF THE PROPORTION OF PATIENTS WITH SLE RECEIVING OFF-LABEL TREATMENT WITH RITUXIMAB IN EUROPEAN COUNTRIES Org: Medicine, Karolinska Institute, Stockholm, Sweden, Rheumatology, Rigshospitalet, Copenhagen, Denmark, Medicine, Charite University Hospitals, Berlin, Germany, Divisions of Rheumatology and Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy, Rheumatology, Catholic University of Louvain, Brussels, Belgium,
Abstract
BASELINE CHARACTERISTICS OF PATIENTS RECEIVING BIOLOGIC AND TRADITIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD) THERAPY IN ONTARIO: RESULTS FROM THE ONTARIO BIOLOGICS RESEARCH INITIATIVE Org: University of Toronto, University Health Network, Division of Clinical Epidemiology, Research Institute of the McGill Univ. Health, Montreal, Canada, McGill University Health Center, McMaster University and Juravinski Cancer Centre,